Rationale for a nanomedicine approach to thrombolytic therapy.
Lanza
Gregory M
GM
Department of Medicine, Division of Cardiology, 4320 Forest Park Ave, Suite 101, St Louis, MO 63108, USA. greg@cvu.wustl.edu
Marsh
Jon N
JN
Hu
Grace
G
Scott
Michael J
MJ
Schmieder
Anne H
AH
Caruthers
Shelton D
SD
Pan
Dipanjan
D
Wickline
Samuel A
SA
D002545:Brain Ischemia / Q000628:therapy*; D006801:Humans; D050997:Nanomedicine; D020521:Stroke / Q000628:therapy*; D015912:Thrombolytic Therapy / Q000379:methods*